<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="../rssStyle.xslt" version="1.0"?>
<rss version="2.0">
  <channel>
    <title>Biocompare Neuroscience</title>
    <description>Biocompare.com RSS feed</description>
    <link>http://www.biocompare.com/</link>
    <copyright>&amp;copy; 2010 Biocompare.com</copyright>
    <pubDate>Sun, 01 Aug 2010 02:03:48 GMT</pubDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>Memory's Master Switch</title>
      <description>Neuroscientists have long wondered how individual connections between brain cells remain diverse and "fit" enough for storing new memories. Reported in the prestigious science journal Neuron, a new study led by Dr. Inna Slutsky of the Sackler School of Medicine at Tel Aviv University describes what makes some memories stick.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335974</link>
      <author>Biocompare.com</author>
      <pubDate>Fri, 30 Jul 2010 13:53:00 GMT</pubDate>
    </item>
    <item>
      <title>New Pathway To Parkinson's And Alzheimer's Diseases</title>
      <description>LA JOLLA, Calif., July 29, 2010 - Although their genetic underpinnings differ, Alzheimer's disease, Parkinson's disease and Huntington's disease are all characterized by the untimely death of brain cells. What triggers cell death in the brain? According to a new study published by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) in the July 30 issue of Molecular Cell, the answer in some cases is the untimely transfer of a gaseous molecule (known as nitric oxide, or NO) from one protein to another.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335971</link>
      <author>Biocompare.com</author>
      <pubDate>Fri, 30 Jul 2010 13:47:00 GMT</pubDate>
    </item>
    <item>
      <title>Scripps Research Study Opens The Door To New Class Of Drugs For Epileptic Seizures</title>
      <description>LA JOLLA, CA - July 28, 2010 - For Immediate Release - A chemical compound that boosts the action of a molecule normally produced in the brain may provide the starting point for a new line of therapies for the treatment of epileptic seizures, according to a new study by scientists at The Scripps Research Institute.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335946</link>
      <author>Biocompare.com</author>
      <pubDate>Fri, 30 Jul 2010 10:57:00 GMT</pubDate>
    </item>
    <item>
      <title>Multiple Sclerosis - Antihypertensive Drug Ameliorate Inflammation In The Brain</title>
      <description>Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis (MS) in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335767</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 15:32:00 GMT</pubDate>
    </item>
    <item>
      <title>Electrical Activity In Developing Brain Influences Choice Of Neurotransmitter</title>
      <description>Cascades of genetic signals determine which neurotransmitter a brain cell will ultimately use to communicate with other cells. Now a pair of reports from biologists at the University of California, San Diego, have shown for the first time that electrical activity in these developing neurons can alter their chemical fate-and change an animal's behavior-by tweaking this genetic program.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335766</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 15:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Molecular Mechanism Triggering Parkinson's Disease Identified In Stanford Study</title>
      <description>STANFORD, Calif. - Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson's disease. This discovery not only may explain how a genetic mutation linked to Parkinson's causes the cells' death, but could also open the door to new therapeutic approaches for the malady.

</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335764</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 15:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Protease Associated With Damage After Stroke Implicated In Huntington's Toxicity</title>
      <description>A new study reveals that an enzyme linked with multiple disorders is also involved in the generation of toxic, neuron-killing protein fragments in Huntington's disease (HD). The research, published by Cell Press in the July 29 issue of Neuron, provides insight into Huntington's pathology and proposes new therapeutic strategies for this devastating incurable disease.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335762</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 13:08:00 GMT</pubDate>
    </item>
    <item>
      <title>Leap Forward In Efforts To Develop Treatments For Huntington's Disease</title>
      <description>Scientists at the Buck Institute for Age Research have discovered that a particular family of enzymes are involved in the breakdown of proteins that modify the production of toxic fragments that lead to the pathology of Huntington's disease. These enzymes, matrix metalloproteinases (MMPs), provide new targets for drug therapies for the disease - targets that have already been shown to respond to cancer drugs currently in clinical development. Results of the research, from the laboratories of Buck faculty members Lisa Ellerby, Ph.D. and Robert Hughes, Ph.D., appear as the cover story in the July 29, 2010 edition of Neuron.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335761</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 13:07:00 GMT</pubDate>
    </item>
    <item>
      <title>Brainstem, Spinal Cord Images Hidden In Michelangelo's Sistine Chapel Fresco</title>
      <description>Michelangelo, the 16th century master painter and accomplished anatomist, appears to have hidden an image of the brainstem and spinal cord in a depiction of God in the Sistine Chapel's ceiling, a new study by Johns Hopkins researchers reports. These findings by a neurosurgeon and a medical illustrator, published in the May Neurosurgery, may explain long controversial and unusual features of one of the frescoes' figures.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335749</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 10:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Aging And Longevity Tied To Specific Brain Region In Mice</title>
      <description>Researchers watched two groups of mice, both nearing the end of a two-day fast. One group was quietly huddled together, but the other group was active and alert. The difference? The second set of mice had been engineered so their brains produced more SIRT1, a protein known to play a role in aging and longevity.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335747</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 10:25:00 GMT</pubDate>
    </item>
  </channel>
</rss>